JP2006512419A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006512419A5 JP2006512419A5 JP2005509731A JP2005509731A JP2006512419A5 JP 2006512419 A5 JP2006512419 A5 JP 2006512419A5 JP 2005509731 A JP2005509731 A JP 2005509731A JP 2005509731 A JP2005509731 A JP 2005509731A JP 2006512419 A5 JP2006512419 A5 JP 2006512419A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- gmcsf
- pharmaceutical composition
- gcsf
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000926 neurological effect Effects 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims 6
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 6
- 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 claims 6
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims 6
- 210000001178 neural stem cell Anatomy 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 5
- 230000003394 haemopoietic effect Effects 0.000 claims 5
- 206010008118 cerebral infarction Diseases 0.000 claims 3
- 230000000638 stimulation Effects 0.000 claims 3
- 201000006474 Brain Ischemia Diseases 0.000 claims 2
- 206010008120 Cerebral ischaemia Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 1
- 102000003951 Erythropoietin Human genes 0.000 claims 1
- 108090000394 Erythropoietin Proteins 0.000 claims 1
- 208000010496 Heart Arrest Diseases 0.000 claims 1
- 102000015696 Interleukins Human genes 0.000 claims 1
- 108010063738 Interleukins Proteins 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
- 230000002424 anti-apoptotic effect Effects 0.000 claims 1
- 230000008499 blood brain barrier function Effects 0.000 claims 1
- 210000001218 blood-brain barrier Anatomy 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- 229940105423 erythropoietin Drugs 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 229960000187 tissue plasminogen activator Drugs 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33175502A | 2002-12-31 | 2002-12-31 | |
| US10/331,755 | 2002-12-31 | ||
| US10/659,295 | 2003-09-11 | ||
| US10/659,295 US7785601B2 (en) | 2002-12-31 | 2003-09-11 | Methods of treating neurological conditions with hematopoietic growth factors |
| PCT/IB2003/006446 WO2004058287A2 (en) | 2002-12-31 | 2003-12-31 | Methods of treating neurological conditions with hematopoeitic growth factors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010199712A Division JP2010270158A (ja) | 2002-12-31 | 2010-09-07 | Ｇｃｓｆまたはｇｃｓｆをコードするヌクレオチドの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006512419A JP2006512419A (ja) | 2006-04-13 |
| JP2006512419A5 true JP2006512419A5 (enExample) | 2008-02-21 |
| JP4733521B2 JP4733521B2 (ja) | 2011-07-27 |
Family
ID=32710846
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005509731A Expired - Fee Related JP4733521B2 (ja) | 2002-12-31 | 2003-12-31 | 造血成長因子での、神経状態を処置する方法 |
| JP2010199712A Pending JP2010270158A (ja) | 2002-12-31 | 2010-09-07 | Ｇｃｓｆまたはｇｃｓｆをコードするヌクレオチドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010199712A Pending JP2010270158A (ja) | 2002-12-31 | 2010-09-07 | Ｇｃｓｆまたはｇｃｓｆをコードするヌクレオチドの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (8) | US7785601B2 (enExample) |
| EP (2) | EP2186525A3 (enExample) |
| JP (2) | JP4733521B2 (enExample) |
| CN (3) | CN101926981A (enExample) |
| AT (1) | ATE450268T1 (enExample) |
| AU (1) | AU2009201467A1 (enExample) |
| DE (1) | DE60330390D1 (enExample) |
| RU (1) | RU2008146718A (enExample) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1019082B2 (en) * | 1997-10-02 | 2008-06-04 | Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. | Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| WO2004011632A2 (en) * | 2002-07-30 | 2004-02-05 | Stem Cell Therapeutics Inc. | Oligodendrocyte production from multipotent neural stem cells |
| US7785601B2 (en) * | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| US7695723B2 (en) * | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| AU2003299430B2 (en) * | 2002-12-31 | 2009-01-08 | Neurovision-Pharma Gmbh | Methods of treating neurological conditions with hematopoeitic growth factors |
| MXPA05012880A (es) | 2003-06-02 | 2006-02-22 | Evolutec Ltd | Inhibidores de complemento. |
| WO2006055260A2 (en) * | 2004-11-05 | 2006-05-26 | Northwestern University | Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
| US20060257943A1 (en) * | 2005-01-25 | 2006-11-16 | Cis Biotech, Inc. | Ischemic biomarkers and their use to predict adverse neurological events from surgery |
| WO2007019522A2 (en) * | 2005-08-04 | 2007-02-15 | Carlos Lopez | Reversal of adult onset disorders with granulocyte-colony stimulating factors |
| CN101283090A (zh) * | 2005-08-19 | 2008-10-08 | 联邦科学及工业研究组织 | 菌蚋荧光素酶 |
| GB0518443D0 (en) | 2005-09-09 | 2005-10-19 | Evolutec Ltd | Method of treating myasthenia gravis |
| US9770485B2 (en) * | 2006-02-21 | 2017-09-26 | Academia Sinica | Methods for rescuing learning and/or memory deficits caused by alzheimer's disease by G-CSF |
| US20070196279A1 (en) * | 2006-02-21 | 2007-08-23 | Shen Che-Kun J | Methods for treating progressive neurodegenerative disorders |
| WO2007105305A1 (ja) * | 2006-03-14 | 2007-09-20 | Japan Tobacco Inc. | 新規なβ－ガラクトシド－α２，６－シアル酸転移酵素、それをコードする遺伝子およびその製造方法 |
| JP5153114B2 (ja) * | 2006-10-12 | 2013-02-27 | 知宏 千葉 | 新規のアルツハイマー病検出方法 |
| KR100812274B1 (ko) * | 2006-10-30 | 2008-03-13 | 한양대학교 산학협력단 | Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제 |
| WO2008060610A2 (en) * | 2006-11-17 | 2008-05-22 | Biogen Idec Ma Inc. | Systemic administration of colony stimulating factors to treat amyloid associated disorders |
| CN101573447A (zh) * | 2006-12-29 | 2009-11-04 | 赢创德固赛有限责任公司 | 具有降低的产物抑制作用的甲硫氨酸合酶 |
| US7618938B2 (en) * | 2007-02-07 | 2009-11-17 | Academia Sinica | Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly |
| US7723302B2 (en) * | 2007-05-01 | 2010-05-25 | Florida Atlantic University | Method of treating Parkinson's disease |
| JP4927774B2 (ja) * | 2007-10-12 | 2012-05-09 | サントリーホールディングス株式会社 | Ｕｄｐ−グルクロン酸転移酵素およびそれをコードするポリヌクレオチド |
| US8119367B2 (en) * | 2007-10-22 | 2012-02-21 | University Of Florida Research Foundation, Inc. | Nucleic acids, compositions and uses thereof |
| TW200948964A (en) * | 2008-04-17 | 2009-12-01 | Novozymes As | Laccase variants |
| US9132168B2 (en) | 2008-08-05 | 2015-09-15 | University Of South Florida | Methods of treating cognitive impairment |
| EP2320934A4 (en) | 2008-08-05 | 2012-08-01 | Univ South Florida | PROCESS FOR TREATING COGNITIVE IMPAIRMENT |
| SG10201807935SA (en) * | 2008-09-04 | 2018-10-30 | Abt Holding Co | Use of stem cells to prevent neuronal dieback |
| EP2362899A1 (en) | 2008-10-31 | 2011-09-07 | Katholieke Universiteit Leuven | Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells |
| RU2011138165A (ru) * | 2009-02-17 | 2013-03-27 | Зигнис Байосайенс Гмбх Унд Ко. Кг | Применение g-csf для удлинения периода "терапевтического окна" тромболитического лечения инсульта |
| EP3831930A1 (en) * | 2009-07-21 | 2021-06-09 | ABT Holding Company | Use of stem cells to reduce leukocyte extravasation |
| ES2690199T3 (es) * | 2009-07-21 | 2018-11-19 | Abt Holding Company | Uso de células madre para reducir la extravasación de leucocitos |
| EP2502079B1 (en) * | 2009-11-20 | 2015-01-28 | Pharnext | New diagnostic tools for charcot-marie-tooth disease |
| CA2781399C (en) | 2009-11-25 | 2015-01-20 | Codexis, Inc. | Recombinant thermoascus aurantiacus beta-glucosidase variants for production of fermentable sugars from cellulosic biomass |
| CN102762223B (zh) | 2010-01-08 | 2014-09-03 | 沃卢申伊谬诺制药公司 | 用于治疗呼吸道病毒性感染的ev576 |
| US20160208011A1 (en) | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
| US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
| US10626399B2 (en) | 2010-01-28 | 2020-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) |
| US9795652B2 (en) * | 2010-02-25 | 2017-10-24 | University Of South Florida | Use of endogenous antioxidant proteins in the treatment of stroke |
| CN102260343A (zh) | 2010-05-25 | 2011-11-30 | 健能隆医药技术（上海）有限公司 | 重组人g-csf二聚体在治疗神经损伤疾病中的用途 |
| US9090878B2 (en) | 2010-06-17 | 2015-07-28 | Katholieke Universiteit Leuven | Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells |
| GB201011589D0 (en) * | 2010-07-09 | 2010-08-25 | Reneuron Ltd | Therapeutic cells |
| US20130261165A1 (en) * | 2010-12-16 | 2013-10-03 | The Mclean Hospital Corporation | Prevention and treatment of diseases characterized by mesencephalic dopaminergic neuron cell death |
| US9161968B2 (en) * | 2011-04-08 | 2015-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
| CN102212542B (zh) * | 2011-04-11 | 2012-12-19 | 上海赛伦生物技术有限公司 | 重组马gmcsf的制备方法及相关马gmcsf核苷酸序列 |
| WO2013016223A2 (en) * | 2011-07-22 | 2013-01-31 | The University Of Chicago | Treatments for migraine and related disorders |
| EP2737905B1 (en) | 2011-07-25 | 2019-09-11 | Generon (Shanghai) Corporation Ltd. | Use of g-csf dimer in preparation of medicament for treatment of neurodegenerative diseases |
| WO2013036526A1 (en) * | 2011-09-06 | 2013-03-14 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
| US9632075B2 (en) * | 2011-11-01 | 2017-04-25 | Meselex, Inc. | Prevention or attenuation of neuropathic pain by bile acids |
| US8889630B2 (en) * | 2011-12-23 | 2014-11-18 | Carlos Lopez | Method for hair regrowth using Granulocyte-Colony Stimulating Factor |
| WO2013149064A1 (en) * | 2012-03-30 | 2013-10-03 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells |
| CN113559281A (zh) * | 2012-07-19 | 2021-10-29 | 宾夕法尼亚州研究基金会 | 再生用于在神经系统中治疗疾病和损伤的功能性神经元 |
| CN103193882B (zh) * | 2013-03-29 | 2014-11-05 | 浙江大学 | 胚胎干细胞特异性标志物GM-CSFRα及其应用 |
| EP3795159A1 (en) | 2013-04-12 | 2021-03-24 | Houston Methodist Hospital | Improving organs for transplantation |
| US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
| WO2015088915A1 (en) | 2013-12-09 | 2015-06-18 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
| WO2015185602A1 (en) * | 2014-06-04 | 2015-12-10 | Affiris Ag | Treatment and prevention of parkinson's disease (pd) |
| US10039808B2 (en) | 2014-10-22 | 2018-08-07 | Michael Chez | Method of treating or improving neurological function in a human subject |
| US9925244B1 (en) | 2015-02-17 | 2018-03-27 | Michael Chez | Treatment of warts in non-immunosuppressed patients |
| ES2902467T3 (es) | 2015-06-15 | 2022-03-28 | Univ Leland Stanford Junior | TIMP2 para su uso en el tratamiento de afecciones asociadas al envejecimiento |
| EP3995141B1 (en) | 2016-04-28 | 2024-01-03 | Alkahest, Inc. | Plasma fractions as therapy for thymic cancer |
| US10525107B2 (en) | 2016-08-18 | 2020-01-07 | Alkahest, Inc. | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
| AU2018257921B2 (en) | 2017-04-26 | 2024-06-06 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| CN113893328A (zh) * | 2017-06-14 | 2022-01-07 | 天津医科大学总医院 | 一种人源乳凝集素亚型蛋白的新用途 |
| US10863912B2 (en) | 2017-08-24 | 2020-12-15 | Myneurva Holdings, Inc. | System and method for analyzing electroencephalogram signals |
| AR113756A1 (es) | 2017-10-11 | 2020-06-10 | Ambrx Inc | Variantes porcinas de g-csf y sus usos |
| US11692029B2 (en) | 2018-03-05 | 2023-07-04 | The Schepens Eye Research Institute, Inc. | Therapy for glaucoma and optic neuropathy by targeting colony stimulating factors |
| MX2021004755A (es) | 2018-10-26 | 2021-06-08 | Alkahest Inc | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria. |
| US20250134959A1 (en) * | 2022-02-11 | 2025-05-01 | Partner Therapeutics, Inc. | Granulocyte-macrophage colony-stimulating factor-based treatments for neurodegenerative or neurological diseases or disorders |
| US20240058419A1 (en) * | 2022-08-22 | 2024-02-22 | Buddhist Tzu Chi Medical Foundation | Method for treating optic neuropathy |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4810643A (en) * | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
| US6004548A (en) | 1985-08-23 | 1999-12-21 | Amgen, Inc. | Analogs of pluripotent granulocyte colony-stimulating factor |
| US5641663A (en) | 1985-11-06 | 1997-06-24 | Cangene Corporation | Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from steptomyces |
| CA1297005C (en) * | 1986-01-22 | 1992-03-10 | Masahiko Tamura | Pharmaceutical agent for the treatment of myelogenous leukemia |
| DK203187A (da) | 1986-04-22 | 1987-10-23 | Immunex Corp | Human g-csf proteinekspression |
| EP0327545B1 (en) | 1986-09-30 | 1996-12-04 | Colloidal Dynamics Pty. Ltd. | Determination of particle size and electric charge |
| NO176799C (no) | 1986-12-23 | 1995-05-31 | Kyowa Hakko Kogyo Kk | DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid |
| US5214132A (en) | 1986-12-23 | 1993-05-25 | Kyowa Hakko Kogyo Co., Ltd. | Polypeptide derivatives of human granulocyte colony stimulating factor |
| GB2213821B (en) | 1987-12-23 | 1992-01-02 | British Bio Technology | Synthetic human granulocyte colony stimulating factor gene |
| US4904584A (en) | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
| US5599690A (en) * | 1988-02-01 | 1997-02-04 | Amgen Inc. | Control of norleucine incorporation into recombinant proteins |
| US5021239A (en) | 1988-03-21 | 1991-06-04 | Genetics Institute, Inc. | Use of M-CSF to improve lipoprotein cholesterol profiles |
| CA1340810C (en) | 1988-03-31 | 1999-11-02 | Motoo Yamasaki | Polypeptide derivatives of human granulocyte colony stimulating factor |
| DE68918331T2 (de) | 1988-06-03 | 1995-05-18 | Chugai Pharmaceutical Co Ltd | Menschlicher kristallinischer Granulocyt-Koloniestimulierungsfaktor und dessen Herstellung. |
| US5218092A (en) | 1988-09-29 | 1993-06-08 | Kyowa Hakko Kogyo Co., Ltd. | Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains |
| US5166322A (en) | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
| US5629283A (en) | 1989-08-11 | 1997-05-13 | Amrad Corporation Limited | Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| EP0439952A3 (en) | 1990-01-31 | 1992-09-09 | Sgs-Thomson Microelectronics, Inc. | Dual-port cache tag memory |
| US5492534A (en) | 1990-04-02 | 1996-02-20 | Pharmetrix Corporation | Controlled release portable pump |
| GB9107846D0 (en) | 1990-04-30 | 1991-05-29 | Ici Plc | Polypeptides |
| DE4014750A1 (de) | 1990-05-08 | 1991-11-14 | Boehringer Mannheim Gmbh | Muteine des granulozyten-stimulierenden faktors (g-csf) |
| JP2946231B2 (ja) | 1990-05-31 | 1999-09-06 | 株式会社栗本鐵工所 | 超微粉分級機 |
| JPH04198134A (ja) | 1990-11-28 | 1992-07-17 | Eisai Co Ltd | 老人性痴呆症の治療・予防剤 |
| DE4105480A1 (de) | 1991-02-21 | 1992-08-27 | Boehringer Mannheim Gmbh | Verbesserte aktivierung von rekombinanten proteinen |
| JP3537151B2 (ja) | 1991-12-26 | 2004-06-14 | 中外製薬株式会社 | 脳機能障害による疾患の予防・治療薬 |
| US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
| EP0661057A4 (en) * | 1993-06-08 | 1997-09-03 | Ajinomoto Kk | ACCELERATOR OF THE PROLIFERATION OF HEMATOPIETIC CELLS. |
| US6465616B1 (en) * | 1994-04-08 | 2002-10-15 | Bresagen Limited | Interleukin-5 antagonist |
| US5585245A (en) | 1994-04-22 | 1996-12-17 | California Institute Of Technology | Ubiquitin-based split protein sensor |
| US5474552A (en) | 1994-06-27 | 1995-12-12 | Cb-Carmel Biotechnology Ltd. | Implantable drug delivery pump |
| DE19518505A1 (de) | 1995-05-19 | 1996-11-21 | Max Planck Gesellschaft | Verfahren zur Genexpressionsanalyse |
| US5995860A (en) | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
| US6121246A (en) | 1995-10-20 | 2000-09-19 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for treating ischemic tissue |
| CA2213906A1 (en) * | 1996-09-23 | 1998-03-23 | Dusica Maysinger | Pharmaceutical composition and method for neuron rescue in ischemic stroke |
| JPH10158188A (ja) * | 1996-11-29 | 1998-06-16 | Senju Pharmaceut Co Ltd | 角膜治療用組成物 |
| US5895647A (en) * | 1996-12-20 | 1999-04-20 | The United States Of America As Represented By The Secretary Of The Navy | Use of oral interleukin-6 as therapy for hemorrhagic shock |
| JP3503418B2 (ja) | 1997-05-15 | 2004-03-08 | ミノルタ株式会社 | 誘導加熱定着装置 |
| US20010049381A1 (en) * | 1997-06-04 | 2001-12-06 | Gpl Nil Holdings, Inc., | Pyrrolidine derivative hair growth compositions and uses |
| US6093167A (en) | 1997-06-16 | 2000-07-25 | Medtronic, Inc. | System for pancreatic stimulation and glucose measurement |
| EP1019082B2 (en) | 1997-10-02 | 2008-06-04 | Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. | Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| US6617171B2 (en) * | 1998-02-27 | 2003-09-09 | The General Hospital Corporation | Methods for diagnosing and treating autoimmune disease |
| CA2323638A1 (en) | 1998-04-03 | 1999-10-14 | Phylos, Inc. | Addressable protein arrays |
| US6630470B1 (en) | 1998-05-22 | 2003-10-07 | Smithkline Beecham Corporation | G-CSF mimetics |
| CA2332317A1 (en) | 1998-05-22 | 1999-12-02 | Smithkline Beecham Corporation | G-csf mimetics |
| US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| DE69934337T2 (de) | 1998-07-22 | 2007-05-24 | Osprey Pharmaceuticals Ltd., Calgary | Konjugate zur Behandlung von Entzündungskrankheiten und von assozierter Gewebeschädigung |
| US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| US6261250B1 (en) | 1998-08-20 | 2001-07-17 | Rle Corporation | Method and apparatus for enhancing cardiovascular activity and health through rhythmic limb elevation |
| US6610540B1 (en) | 1998-11-18 | 2003-08-26 | California Institute Of Technology | Low oxygen culturing of central nervous system progenitor cells |
| EP1157037B1 (en) | 1999-01-29 | 2003-07-30 | F. Hoffmann-La Roche Ag | Gcsf conjugates |
| WO2001040456A1 (en) * | 1999-12-03 | 2001-06-07 | Human Genome Sciences, Inc. | Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| DE10033219A1 (de) | 2000-07-07 | 2002-01-24 | Univ Heidelberg | Neuroprotektive Wirkung von Granulocyten-Colony Stimmulierendem Faktor (G-CSF) |
| CA2420765A1 (en) * | 2000-09-01 | 2002-03-07 | Bioacta Ltd | Anti-angiogenic peptides |
| CA2421760A1 (en) * | 2000-09-08 | 2002-03-14 | Massachusetts Institute Of Technology | G-csf analog compositions and methods |
| CN1466463A (zh) | 2000-09-13 | 2004-01-07 | 中外制药株式会社 | 缺血性疾病治疗剂 |
| WO2002037968A1 (en) * | 2000-11-10 | 2002-05-16 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| ATE365561T1 (de) | 2001-03-12 | 2007-07-15 | Inst Of Gene And Brain Science | Verwendung von interleukin-12 zur behandlung von nervenschäden |
| JP3763749B2 (ja) | 2001-03-28 | 2006-04-05 | 独立行政法人科学技術振興機構 | 脊髄におけるシナプス形成ニューロンを誘導する中枢神経系前駆細胞 |
| AU2002316201A1 (en) * | 2001-06-07 | 2002-12-16 | Quark Biotech, Inc. | Methods of using colony stimulating factors in the treatment of tissue damage and ischemia |
| FR2834898B1 (fr) | 2002-01-18 | 2005-06-10 | Didier Pourquier | Nouvelle application therapeutique du g-csf, du gm-csf et du scf |
| DE10211063A1 (de) | 2002-03-13 | 2003-10-09 | Axaron Bioscience Ag | Neue Verfahren zur Detektion und Analyse von Protein-Interaktionen in vivo |
| US20050142101A1 (en) | 2002-05-10 | 2005-06-30 | Ulf Forssmann | Method of inhibiting the emigration of cells from the intravascular compartment into tissues |
| SI1505973T1 (sl) * | 2002-05-17 | 2010-06-30 | Celgene Corp | Kombinacija za zdravljenje multiplega mieloma |
| NZ536908A (en) * | 2002-05-17 | 2008-09-26 | Celgene Corp | Treating or preventing cancer comprising administering an effective amount of cytokine inhibitory drug plus a second active ingredient |
| WO2004011632A2 (en) | 2002-07-30 | 2004-02-05 | Stem Cell Therapeutics Inc. | Oligodendrocyte production from multipotent neural stem cells |
| WO2004037196A2 (en) * | 2002-10-24 | 2004-05-06 | Sangstat Medical Corporation | Cytomodulating peptides and methods for treating neurological disorders |
| US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| US7695723B2 (en) * | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| JP4198134B2 (ja) | 2005-04-13 | 2008-12-17 | 京セラミタ株式会社 | 給紙装置 |
| EP2036571A1 (de) * | 2007-09-13 | 2009-03-18 | Sygnis Bioscience GmbH & Co. KG | Verwendung von G-CSF für die Behandlung von Schlaganfall |
-
2003
- 2003-09-11 US US10/659,295 patent/US7785601B2/en not_active Expired - Fee Related
- 2003-12-31 JP JP2005509731A patent/JP4733521B2/ja not_active Expired - Fee Related
- 2003-12-31 CN CN2009101755154A patent/CN101926981A/zh active Pending
- 2003-12-31 AT AT03799727T patent/ATE450268T1/de not_active IP Right Cessation
- 2003-12-31 EP EP09011942A patent/EP2186525A3/en not_active Withdrawn
- 2003-12-31 EP EP10011006A patent/EP2311483A1/en not_active Withdrawn
- 2003-12-31 CN CNB2003801100755A patent/CN100558397C/zh not_active Expired - Fee Related
- 2003-12-31 DE DE60330390T patent/DE60330390D1/de not_active Expired - Lifetime
- 2003-12-31 CN CN200910175516A patent/CN101693107A/zh active Pending
-
2007
- 2007-08-29 US US11/846,699 patent/US20080279814A1/en not_active Abandoned
- 2007-10-31 US US11/931,326 patent/US20080171080A1/en not_active Abandoned
- 2007-10-31 US US11/931,618 patent/US20080181865A1/en not_active Abandoned
- 2007-10-31 US US11/931,295 patent/US8071543B2/en not_active Expired - Fee Related
- 2007-10-31 US US11/930,758 patent/US7884069B2/en not_active Expired - Fee Related
- 2007-10-31 US US11/932,383 patent/US8053407B2/en not_active Expired - Fee Related
-
2008
- 2008-11-26 RU RU2008146718/15A patent/RU2008146718A/ru not_active Application Discontinuation
-
2009
- 2009-04-07 AU AU2009201467A patent/AU2009201467A1/en not_active Abandoned
-
2010
- 2010-09-07 JP JP2010199712A patent/JP2010270158A/ja active Pending
-
2012
- 2012-02-02 US US13/364,381 patent/US20120231065A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006512419A5 (enExample) | ||
| EP2548880A3 (en) | Compositions for increasing telomerase activity | |
| Dai et al. | Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury | |
| WO2005044179A3 (en) | Formulations containing astragalus extracts and uses thereof | |
| WO2010057112A3 (en) | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets | |
| EP2422797A3 (en) | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation | |
| WO2007149310A3 (en) | Multiphasic biofunctional nano-components and methods for use thereof | |
| JP2021191771A5 (enExample) | ||
| CA2518219A1 (en) | Igf-binding protein-derived peptide or small molecule | |
| ITTO20121107A1 (it) | Composizione a base di polidesossiribonucleotidi e relativi usi | |
| GEP20094781B (en) | Sulfonamide derivatives for the treatment of diseases | |
| Andrews | Amyotrophic lateral sclerosis: clinical management and research update | |
| WO2006078782A3 (en) | Compositions containing agm cells and methods of use thereof | |
| CA2348882A1 (en) | Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol | |
| ITRM970238A0 (it) | Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella terapia di patologie corneali e congiuntivali | |
| Feng et al. | Stromal cell-derived factor 1 protects human periodontal ligament stem cells against hydrogen peroxide-induced apoptosis | |
| WO2005123651A8 (fr) | L-2-(a-hydroxypentyle)benzoates, leur elaboration et leur utilisation | |
| CN107050060A (zh) | 治疗牛皮癣的外用药及药物组合物 | |
| Bruetsch et al. | THE PARKINSONIAN SYNDROME DUE TO TRAUMA*: A Clinico-Anatomical Study of A Case | |
| Shalev et al. | Symptomatic Brugada unmasked by fever | |
| CN105106093B (zh) | 一种面部年轻化美容制剂及其制备方法 | |
| WO2006071603A3 (en) | Phosphodiesterase 4d in the ryanodine receptor complex protects against heart failure | |
| Harper | NEW THERAPEUTIC APPROACHES: I. 8Emerging therapeutic approaches for Facioscapulohumeral muscular dystrophy (FSHD) | |
| Xie et al. | Stem cells for the treatment of neuropathic pain | |
| Le Gall et al. | NEW INSIGHTS INTO CELLULAR FUNCTIONS: O. 11Secretion of toxic exosomes by muscle cells of ALS patients |